USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities
Naiara Perurena(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital)
Cited by 12
Related Papers
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
|Journal of Clinical Investigation|2016|43
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
|Journal of Clinical Investigation|2023|20